Xylem Inc. (XYL) · Oct 27, 2026 · Earnings
Miss — Adjusted EPS $1.44 vs ~$1.45–$1.47 consensus; revenue $2.20B vs ~$2.28B
Xylem’s Q3 earnings came in slightly below expectations, while weaker project timing drove cuts to full-year revenue and adjusted EPS guidance.
Xylem is in the middle of a portfolio and operating-model reset: it is simplifying its water businesses, exiting less strategic assets, and aiming to increase exposure to higher-growth areas such as data centers and microelectronics. This quarter shows the transformation improving profitability, but not yet overcoming softer project timing and customer spending caution.
The quarter missed on both major top-line measures. Revenue fell 3% year over year to $2.201 billion, versus a published consensus near $2.28 billion, while adjusted EPS was $1.44 versus roughly $1.45–$1.47 expected. Reported EPS was $1.25, up from $0.93 a year ago, but the earnings comparison benefited from lower losses on business sales and other adjustments rather than stronger sales growth. The company said revenue was affected by “project timing and more cautious spending decisions.”
| Metric | Q3 2026 | Q3 2025 / prior guide | Read |
|---|---|---|---|
| Revenue | $2.201B | $2.268B | Down 3%; below ~$2.28B consensus |
| Adjusted EPS | $1.44 | $1.37 | Up 5%; slightly below ~$1.45–$1.47 consensus |
| Adjusted EBITDA margin | 23.9% | 23.2% | Up 70 bps |
| FY2026 revenue guide | ~$8.95B | Prior: up 2% | Cut to down 1% reported; flat organic |
| FY2026 adjusted EPS guide | $5.40–$5.45 | Prior: $5.55–$5.70 | Cut |
| FY2026 free-cash-flow margin | ~10.2% | Prior: 10.2%–11.0% | Narrowed to the low end |
Profitability was the bright spot, but it did not offset the growth reset. Adjusted EBITDA margin reached 23.9%, helped by productivity savings and pricing, despite lower volumes and unfavorable mix. That supports the case that Xylem’s efficiency program is working; however, the company’s full-year revenue forecast now implies a sharper slowdown than previously expected, and the EPS guide was cut despite the margin progress. 〔0〕
The guidance cut is the central new information. Xylem now expects approximately $8.95 billion of 2026 revenue, down from prior guidance for roughly 2% growth, with organic revenue flat instead of growing 2%–3%. Adjusted EPS is now expected at $5.40–$5.45, below the prior $5.55–$5.70 range.
The portfolio reshaping is strategically coherent but adds execution work. Xylem plans to divest Applied Water International and Specialty Flow Control and reorganize from four segments into three beginning January 1, 2027. The move should make the portfolio simpler and more concentrated around water treatment, flow, and measurement, but the filing provides no transaction proceeds, closing timetable, or quantified benefit, so this is a direction-setting announcement rather than an immediate financial offset to the weaker outlook.
Bottom line: Xylem’s operating discipline is producing better margins, but the more important message is that demand is softer than expected. The earnings miss and full-year guidance cuts outweigh the efficiency gains, while the portfolio reset remains a longer-term execution story rather than a near-term fix.
Three-segment structure begins January 1, 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!